期刊文献+

肿瘤标志物检测在复发性卵巢癌诊治中的意义 被引量:12

原文传递
导出
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2005年第7期389-391,共3页 Chinese Journal of Practical Gynecology and Obstetrics
  • 相关文献

参考文献13

  • 1Cruickshank DJ, Fullerton WT, Klopper A. The clinical significance of preoperative serum CA125 in ovarian cancer. Brit J Obstet Gynaeocol, 1987, 94:682-695
  • 2Nagele F ,Petru E ,Medl M ,et al . Preoperative CA125: an independent prognostic factor in patients with stageⅠ epithelial ovarian cancer. Obstet Gynecol,1995,86(2): 259-264
  • 3Gadducci C. The concomitant determination of different tumor markers on patients with epithelial ovarian cancer and benigh ovarian masses:relevance for differential diagnosis. Gynecol Oncol , 1992,44(2):147
  • 4Kierkegaard O , Mogensen O , Mogensen B , et al. Predictive and prognostic values of cancer associated serum antigen (CASA) and cancer antigen 125(CA125) levels prior to second look laparotomy for ovarian cancer . Gynecol Oncol , 1995 , 59(2): 251-254
  • 5Pressley RH, Muntz HG , Falkenbery S, et al.Serum lactic dehydrogenase as a tumor marker in dysgerminoma . Gynecol Oncol ,1992,44(3): 281-283
  • 6Crombach G , Zippel HH , Wurz H . Clinical significance of cancer antigen 125(CA125) in ovarian cancer . Cancer Detect Prev , 1985, 8(1-2): 135-139
  • 7Crombach G , Zippel HH , Wurz H . Clinical significance of cancer antigen 125(CA125) in ovarian cancer . Acta Obstet Gynecol Scand, 1998, 67(1): 53-58
  • 8Halila H , Lehtovirta P , Stenman UH ,et al . CA125 in the follow-up of patients with ovarian cancer . Acta Obstet Gynecol Scand, 1988, 67(1): 53-58
  • 9Woolas RP,Conaway MR,Xu F, et al . Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic masses . Gynecol Oncol, 1995, 59(1) : 111-116
  • 10Caroline C , Bashir T . Exceptionally high levels of CA125 due to endometriosis . J Obstet Gynaecol , 2002, 22(3): 329-330

同被引文献123

引证文献12

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部